Do we need marker gene studies in humans to improve clinical AAV gene therapy¿

T. Weber

doi:10.1038/gt.2016.84

Do we need marker gene studies in humans to improve clinical AAV gene therapy¿

T. Weber

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Pages (from-to)	72-73
Number of pages	2
Journal	Gene Therapy
Volume	24
Issue number	2
DOIs	https://doi.org/10.1038/gt.2016.84
State	Published - 1 Feb 2017

Access to Document

10.1038/gt.2016.84

Cite this

@article{4cc5a2c027be471ba28c7f8be3e7b1c8,

title = "Do we need marker gene studies in humans to improve clinical AAV gene therapy¿",

author = "T. Weber",

note = "Funding Information: I would like to thank Els Henckaerts, Michael Linden, Fadi Akar and Roger Hajjar for stimulating discussions. This work is supported by R01 HL131404 and a Trans-Atlantic Network of Excellence grant (14CVD03) from the Leducq Foundation.",

year = "2017",

month = feb,

day = "1",

doi = "10.1038/gt.2016.84",

language = "English",

volume = "24",

pages = "72--73",

journal = "Gene Therapy",

issn = "0969-7128",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Do we need marker gene studies in humans to improve clinical AAV gene therapy¿

AU - Weber, T.

N1 - Funding Information: I would like to thank Els Henckaerts, Michael Linden, Fadi Akar and Roger Hajjar for stimulating discussions. This work is supported by R01 HL131404 and a Trans-Atlantic Network of Excellence grant (14CVD03) from the Leducq Foundation.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85008388683&partnerID=8YFLogxK

U2 - 10.1038/gt.2016.84

DO - 10.1038/gt.2016.84

M3 - Comment/debate

C2 - 28054581

AN - SCOPUS:85008388683

SN - 0969-7128

VL - 24

SP - 72

EP - 73

JO - Gene Therapy

JF - Gene Therapy

IS - 2

ER -